Autopsy report · NCT00616902

The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5

“This study was prematurely terminated due to low enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 months before it started.
• Ran for about 4 months before it stopped.
• 12 participants enrolled.
• Results were posted on the registry 1 year 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Abbott

Sponsor type

Industry

Conditions

Chronic Kidney Disease (CKD) Stage 5; Hypertrophy, Left Ventricular

Interventions

paricalcitol injection 4 mcg/mL; Placebo Injection 4 mcg/mL

Participants

12

Sites

76

Countries

Australia, Czechia, Germany, Greece, Italy, Poland, Puerto Rico, Romania, Russia, Spain, Taiwan, United Kingdom and more

Trials that died the same way

• A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients
  “This study was terminated early due to poor enrollment.” (95% match in meaning)
• Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
  “the study was terminated early due to poor enrollment” (95% match in meaning)
• MIRACLE EF Clinical Study
  “The study was terminated early due to low enrollment.” (94% match in meaning)
• Evaluation of the Consumption of a Probiotic on the Load of S. Agalactiae.
  “The study was terminated due to low enrollment” (94% match in meaning)
• A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma
  “Due to low enrollment, this study was terminated early.” (94% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.